Skip to content

EU · EudraLex Vol.4

EU GMP Part I, Chapter 6 6.30

On-going stability programme

Section text

The protocol for an on-going stability programme should extend to the end of the shelf life period and should include, but not be limited to, the following parameters:

i. Number of batch(es) per strength and different batch sizes, if applicable;

ii. Relevant physical, chemical, microbiological and biological test methods;

iii. Acceptance criteria;

iv. Reference to test methods;

v. Description of the container closure system(s);

vi. Testing intervals (time points);

vii. Description of the conditions of storage (standardised ICH/VICH conditions for long term testing, consistent with the product labelling, should be used);

viii. Other applicable parameters specific to the medicinal product.

Source: European Commission, DG SANTE · © European Union. Reuse is authorised provided the source is acknowledged (Commission Decision 2011/833/EU on the reuse of Commission documents). · retrieved 2026-11-15

Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.